184 related articles for article (PubMed ID: 16418684)
1. Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels.
Knoppert DC; Nimkar R; Principi T; Yuen D
Ther Drug Monit; 2006 Feb; 28(1):5-7. PubMed ID: 16418684
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
3. Defective alleles may not have contributed to adverse effects.
Stiskal JA
Ther Drug Monit; 2006 Feb; 28(1):142; author reply 143. PubMed ID: 16418712
[No Abstract] [Full Text] [Related]
4. A new indication for therapeutic drug monitoring in the neonate.
Koren G
Ther Drug Monit; 2006 Feb; 28(1):1. PubMed ID: 16418682
[No Abstract] [Full Text] [Related]
5. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
[TBL] [Abstract][Full Text] [Related]
6. Citalopram serum and milk levels in mother and infant during lactation.
Franssen EJ; Meijs V; Ettaher F; Valerio PG; Keessen M; Lameijer W
Ther Drug Monit; 2006 Feb; 28(1):2-4. PubMed ID: 16418683
[TBL] [Abstract][Full Text] [Related]
7. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?
Isbister GK; Dawson A; Whyte IM; Prior FH; Clancy C; Smith AJ
Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F147-8. PubMed ID: 11561552
[No Abstract] [Full Text] [Related]
8. Perinatal outcome following third trimester exposure to paroxetine.
Costei AM; Kozer E; Ho T; Ito S; Koren G
Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
[TBL] [Abstract][Full Text] [Related]
9. Defective alleles may not have contributed to adverse effects.
Einarson A; Koren G
Ther Drug Monit; 2006 Feb; 28(1):142-3; author reply 143. PubMed ID: 16418711
[No Abstract] [Full Text] [Related]
10. Neonatal paroxetine withdrawal syndrome.
Stiskal JA; Kulin N; Koren G; Ho T; Ito S
Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F134-5. PubMed ID: 11207233
[TBL] [Abstract][Full Text] [Related]
11. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
[TBL] [Abstract][Full Text] [Related]
12. [Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine].
Salvia-Roigés MD; Garcia L; Goncé-Mellgren A; Esqué-Ruiz MT; Figueras-Aloy J; Carbonell-Estrany X
Rev Neurol; 2003 Apr 16-30; 36(8):724-6. PubMed ID: 12717649
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine and neonatal withdrawal syndrome.
Pogliani L; Schneider L; Dilillo D; Penagini F; Zuccotti GV
BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736561
[TBL] [Abstract][Full Text] [Related]
14. Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: still controversial.
Beaulac-Baillargeon L; Boucher N
Arch Pediatr Adolesc Med; 2006 Aug; 160(8):855-6; author reply 856. PubMed ID: 16894088
[No Abstract] [Full Text] [Related]
15. Neonatal signs following exposure to SSRIs.
Hashimoto K
Hum Psychopharmacol; 2005 Oct; 20(7):522. PubMed ID: 16184524
[No Abstract] [Full Text] [Related]
16. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
Nordeng H; Lindemann R; Perminov KV; Reikvam A
Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
[TBL] [Abstract][Full Text] [Related]
17. [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].
Agut-Quijano T; Martínez-Nadal S; Elizari-Saco MJ; Sala-Castellví P; Vila-Cerén C; Raspall-Torrent F
Rev Neurol; 2006 Jun 1-15; 42(11):660-2. PubMed ID: 16736401
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
Koren G; Finkelstein Y; Matsui D; Berkovich M
J Obstet Gynaecol Can; 2009 Apr; 31(4):348-350. PubMed ID: 19497154
[No Abstract] [Full Text] [Related]
19. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.
Bot P; Semmekrot BA; van der Stappen J
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F153. PubMed ID: 16492956
[No Abstract] [Full Text] [Related]
20. Neonatal complications after intrauterine exposure to SSRI antidepressants.
Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
